Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-10

Clinical Trial Update: Omega-3 Fatty Acids for Prevention of Post-Operative Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating whether omega-3 fatty acids prevent postoperative atrial fibrillation has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Atrial Fibrillation | Phase 3 | Status: COMPLETED | Results posted: 2017-04-10